Sector Gamma As as of June 30, 2026
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 40 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 9.1 | $42M | 726k | 57.62 | |
| Merck & Co (MRK) | 6.0 | $28M | 217k | 128.50 | |
| Medtronic SHS (MDT) | 6.0 | $28M | 352k | 78.23 | |
| Pfizer (PFE) | 5.2 | $24M | 1.0M | 24.08 | |
| Incyte Corporation (INCY) | 4.2 | $19M | 171k | 113.36 | |
| Anthem (ELV) | 3.7 | $17M | 45k | 386.73 | |
| BioMarin Pharmaceutical (BMRN) | 3.7 | $17M | 295k | 57.22 | |
| Thermo Fisher Scientific (TMO) | 3.7 | $17M | 34k | 501.36 | |
| CVS Caremark Corporation (CVS) | 3.5 | $16M | 155k | 103.45 | |
| Iqvia Holdings (IQV) | 3.3 | $15M | 78k | 193.22 | |
| Ionis Pharmaceuticals (IONS) | 3.3 | $15M | 190k | 79.29 | |
| Becton, Dickinson and (BDX) | 3.1 | $14M | 93k | 151.33 | |
| Abbott Laboratories (ABT) | 2.9 | $13M | 147k | 90.74 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 2.9 | $13M | 208k | 64.01 | |
| Zimmer Holdings (ZBH) | 2.7 | $12M | 142k | 86.09 | |
| Biogen Idec (BIIB) | 2.5 | $12M | 54k | 216.06 | |
| Qiagen Nv Ord Shares (QGEN) | 2.4 | $11M | 288k | 39.10 | |
| Centene Corporation (CNC) | 2.3 | $10M | 162k | 64.19 | |
| Regeneron Pharmaceuticals (REGN) | 2.1 | $9.8M | 16k | 623.54 | |
| Bio Rad Labs Cl A (BIO) | 2.1 | $9.8M | 33k | 293.61 | |
| Cardinal Health (CAH) | 2.1 | $9.7M | 41k | 237.56 | |
| Amgen (AMGN) | 2.1 | $9.5M | 26k | 362.12 | |
| Bruker Corporation (BRKR) | 2.0 | $9.2M | 152k | 60.18 | |
| Avantor (AVTR) | 1.9 | $9.0M | 906k | 9.90 | |
| Ptc Therapeutics I (PTCT) | 1.8 | $8.2M | 100k | 81.57 | |
| Labcorp Holdings Com Shs (LH) | 1.6 | $7.3M | 26k | 280.00 | |
| Dex (DXCM) | 1.5 | $6.9M | 102k | 67.35 | |
| Ascendis Pharma A/s Ord Shs (ASND) | 1.2 | $5.7M | 21k | 266.72 | |
| Edwards Lifesciences (EW) | 1.2 | $5.5M | 60k | 90.46 | |
| Syndax Pharmaceuticals (SNDX) | 1.1 | $5.3M | 242k | 21.86 | |
| Boston Scientific Corporation (BSX) | 1.1 | $5.2M | 121k | 42.68 | |
| Kura Oncology (KURA) | 1.0 | $4.8M | 433k | 10.97 | |
| Travere Therapeutics (TVTX) | 1.0 | $4.5M | 80k | 56.81 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.9 | $4.3M | 115k | 37.42 | |
| Tandem Diabetes Care Com New (TNDM) | 0.9 | $4.0M | 267k | 15.09 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $4.0M | 969k | 4.16 | |
| Cytokinetics Com New (CYTK) | 0.8 | $3.8M | 45k | 85.19 | |
| Organon & Co Common Stock (OGN) | 0.8 | $3.7M | 271k | 13.54 | |
| Ardelyx (ARDX) | 0.8 | $3.5M | 687k | 5.10 | |
| Intellia Therapeutics (NTLA) | 0.7 | $3.1M | 185k | 16.92 |
